Un estudio encontró que la aspirina de dosis baja no afecta el riesgo de demencia en los pacientes con diabetes
Related Posts
Teachers Have No Higher Risk of Severe COVID-19: Study
THURSDAY, Sept. 2, 2021 (HealthDay News) -- As the new school year begins,...
Couples Age 55 or Older Can Soon Contribute $10,000 a Year to Health Savings Accounts
FRIDAY, May 19, 2023 (HealthDay News) -- New IRS guidance will allow older...
Less Salt, More Whole Grains: FDA Updates Food Label Definition of ‘Healthy’
WEDNESDAY, Sept. 28, 2022 (HealthDay News) -- Salmon can't be labeled a...
Biden to Strengthen Push for Vaccine Mandates in New COVID-19 Plan
THURSDAY, Sept. 9, 2021 (HealthDay News) -- President Joe Biden is slated to...